Services for Pregnant Women with Opiate Use Disorder
Loading...
Date
2018-04
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Ohio State University. Office of Outreach and Engagement
Abstract
Learn about current initiatives to address services for pregnant women with opiate use disorder and babies diagnosed with neonatal abstinence syndrome. To address these myriad concerns, we created a unique community partnership between The Ohio State University Wexner Medical Center (OSUWMC) and Maryhaven's Women's Program. Since 1997, OSUWMC has provided outreach services to more than 2,000 pregnant women struggling with addiction in partnership with Maryhaven's Women Program. Since 2010, more than 500 expectant mothers with opiate use disorder have received high-risk obstetrics care at OSUWMC's Substance Abuse, Treatment, Education and Prevention Program (STEPP) clinic. Both programs work from a model of harm reduction rather than harm elimination.
Description
The presentation will highlight the best practices of both Stable Cradle and The Ohio State University Wexner Medical Center's (OSUWMC) Substance Abuse, Treatment, Education and Prevention Program (STEPP) clinics as a model to address the issues of pregnant women with opiate use disorders. Wanda Dillard, MS, will provide a history of the Stable Cradle Program, and Dr. Mona Prasad will provide overview of the OSUWMC STEPP clinic operations and how the two programs work together. The presentation will further discuss current initiatives to address the opiate epidemic. In Franklin County, at least 353 people overdosed in 2016. The number of babies diagnosed with neonatal abstinence syndrome (NAS) increased by 750 percent in Ohio from 2004-2015. NAS is a set of symptoms associated with abrupt withdrawal of opioids and other drugs when infants are born to mothers with opiate use disorder. In 2013, there were 1,691 drug-dependent babies admitted to Ohio hospitals with a cost for their care at nearly $100 million. Since the beginning of 2017, 40 NAS infants have been admitted to Franklin County nurseries and treated for withdrawal symptoms with a length stay of 28 days (86 percent of the women were white and 13 percent were African American.) Since 1997, OSUWMC has provided outreach services to more than 2,000 pregnant women struggling with addiction in partnership with Maryhaven's Women Program. Since 2010, more than 500 expectant mothers with opiate use disorder have received high-risk obstetrics care at OSUWMC's STEPP clinic. Both programs work from a model of harm reduction rather than harm elimination. OSUWMC's STEPP clinic currently provides high-risk obstetric services for opiate disorders and resources one full day each week. The Maryhaven Women Program's addiction specialist and the two mentors each provide 40 hours a week to conduct outreach with pregnant women on substances.
AUTHOR AFFILIATION: Wanda Dillard, Director of Community Development, The Ohio State UniversityWMC, dillard.19@osu.edu (Corresponding Author); Mona Prasad, Physician, Maternal Fetal Medicine, The Ohio State UniversityWMC.
AUTHOR AFFILIATION: Wanda Dillard, Director of Community Development, The Ohio State UniversityWMC, dillard.19@osu.edu (Corresponding Author); Mona Prasad, Physician, Maternal Fetal Medicine, The Ohio State UniversityWMC.
Keywords
pregnant women opiate use disorder, high-risk obstetric, neonatal abstinence syndrome, addiction treatment and prevention, mentoring peer-to-peer model
Citation
Engaged Scholars, v. 6 (2018).